Avitar - 53 Year Dividend History | AVTI

Historical dividend payout and yield for Avitar (AVTI) since 1972. The current TTM dividend payout for Avitar (AVTI) as of July 03, 2025 is $0.00. The current dividend yield for Avitar as of July 03, 2025 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. The Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company's foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. The Company continues to have applications for its technologies in a variety of other medical/consumer markets. They include a sinus dressing and a device used by astronauts for relieving ear pressure while in a pressurized space suit. Customers for these products include ArthroCare and National Aeronautics and Space Administration (NASA).
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.993B 21.73
Becton Dickinson (BDX) United States $50.489B 12.50
Cardinal Health (CAH) United States $39.365B 20.62
Straumann Holding AG (SAUHY) Switzerland $21.287B 0.00
West Pharmaceutical Services (WST) United States $15.968B 33.47
Cooper (COO) United States $14.659B 18.89
Align Technology (ALGN) United States $14.266B 28.32
Henry Schein (HSIC) United States $9.089B 15.59
Merit Medical Systems (MMSI) United States $5.531B 26.74
DENTSPLY SIRONA (XRAY) United States $3.322B 9.92
CONMED (CNMD) United States $1.681B 12.58
STAAR Surgical (STAA) United States $0.885B 0.00
Lifevantage (LFVN) United States $0.173B 17.82
Pro-Dex (PDEX) United States $0.156B 17.08